Prehospital and disaster medicine

topics in cognitive science

neural computing & applications

applied artificial intelligence : aai

[1] SpikingLab: modelling agents controlled by Spiking Neural Networks in Netlogo.

[2] Automatic Identification of Character Types from Film Dialogs.

[3] Becoming Cognitive Science.

[4] interpersonal closeness correlates with social influence on color perception task using human and artificial agents

[5] modelado conceptual de usuarios en ambientes ubicuos mediante agentes y ontologÍas modelagem conceitual de usuÁrios em ambientes ubÍquos mediante agentes e ontologias conceptual user modeling in ubiquitous environments through agents and ontologies

[6] towards recognising learning evidence in collaborative virtual environments: a mixed agents approach

[7] Antimicrobial agents from plants: antibacterial activity of plant volatile oils

[8] Synthesis and characterization of stable silver nanoparticles, Ag-NPs: Discussion on the applications of Ag-NPs as antimicrobial agents

[9] Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.

[10] Antibrowning agents added in polymeric coating applied to avocado fruit slices

[11] A family of molecular sieves containing framework-bound organic structure-directing agents.

[12] Influence of alkali metal cations on the formation of zeolites under hydrothermal conditions with no organic structure directing agents

[13] Physico–chemical Properties, Biological and Environmental Impact of Nb–saponites Catalysts for the Oxidative Degradation of Chemical Warfare Agents

[14] Heavy metal distribution between contaminated soil and Paulownia tomentosa, in a pilot-scale assisted phytoremediation study: influence of different complexing agents

[15] Essential oils compounds as antimicrobial and antibiofilm agents against strains present in the meat industry

[16] Syntheses of bifunctional molecules containing [12]aneN<inf>3</inf> and carbazol moieties as effective DNA condensation agents

[17] Design, synthesis, molecular docking and antibacterial evaluation of novel N-(6, 11-dioxo-dihydro-5h-benzo [B] carbazol-2yl) benzamide derivatives as potent antibacterial agents

[18] Designing a whole cell bioreporter to show antioxidant activities of agents that work by promotion of the KEAP1–NRF2 signaling pathway

[19] The synthesis and evaluation of quinolinequinones as anti-mycobacterial agents.

[20] Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.

[21] Conformational sieving effect of organic structure-directing agents during the synthesis of zeolitic materials

[22] Differential effects of sympatholytic agents on the power spectrum of rats during the cooling-induced hemodynamic perturbations.

[23] Differential effects of sympatholytic agents on the power spectrum of rats during the cooling-induced hemodynamic perturbations.

[24] Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.

[25] Synthesis and biological evaluation of flavone-8-acrylamide derivatives as potential multi-target-directed anti Alzheimer agents and investigation of binding mechanism with acetylcholinesterase.

[26] Design, synthesis and biological evaluation of novel flavone Mannich base derivatives as potential antibacterial agents

[27] Microwave-assisted synthesis of novel bis-flavone dimers as new anticancer agents

[28] Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents

[29] Diversity-oriented synthesis of pyrazoles derivatives from flavones and isoflavones leads to the discovery of promising reversal agents of fluconazole resistance in Candida albicans

[30] Synthesis of 2,3-Dihydro Flavone Coumarins as a Class of Potent Antifungal and Anti-inflammatory Agents

[31] Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance.

[32] Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis.

[33] Synthesis and Bioactivity Evaluation of Novel 2-Salicyloylbenzofurans as Antibacterial Agents.

[34] A Saccharide Chemosensor Array Developed Based on an Indicator Displacement Assay Using a Combination of Commercially Available Reagents.

[35] Insights into the current status of privileged N-heterocycles as antileishmanial agents.

[36] 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.

[37] Effects of Pecan Nut (Carya illinoiensis) and Roselle Flower (Hibiscus sabdariffa) as Antioxidant and Antimicrobial Agents for Sardines (Sardina pilchardus)

[38] Effects of pecan nut (Carya illinoiensis) and roselle flower (Hibiscus sabdariffa) as antioxidant and antimicrobial agents for sardines (Sardina pilchardus)

[39] Cross-coupling of C(sp)-H Bonds with Organometallic Reagents via Pd(II)/Pd(0) Catalysis**

[40] Two macrocyclic pentaaza compounds containing pyridine evaluated as novel chelating agents in copper(II) and nickel(II) overload.

[41] Organometallic uranium(IV) fluoride complexes: Preparation using protonolysis chemistry and reactivity with trimethylsilyl reagents

[42] Biodegradation of phenyl arsenicals in groundwater-natural attenuation of chemical warfare agents

[43] Synthesis and biological evaluation of benzimidazole-linked 1,2,3-triazole congeners as agents.

[44] Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.

[45] Reaction of 3-nitro-1,2,4-triazoles with alkylating agents. 7*. N-monoalkylation by monocyclic α-oxide polymers

[46] Reaction of 3-nitro-1,2,4-triazole widi alkylation agents. 7. N-Monoalkylation by polymers of monocyclic α-oxides

[47] Development and validation of a web-based electronic application in managing antithrombotic agents in patients undergoing GI endoscopy.

[48] Synthesis and Biological Evaluation of Novel 6-Hydroxy-benzo[d][1,3]oxathiol-2-one Schiff Bases as Potential Anticancer Agents

[49] Evaluation of 1,3-benzoxathiol-2-one Derivatives as Potential Antifungal Agents.

[50] Acyl-isothiocyanates as efficient thiocyanate transfer reagents.

[51] Synthesis and biological evaluation of novel 6-hydroxy-benzo[d][1,3]oxathiol-2-one schiff bases as potential anticancer agents

[52] Synthesis of organic bisurea compounds and their roles as crystallization nucleating agents of poly(l-lactic acid)

[53] Hybrid cis-stilbene Molecules: Novel Anticancer Agents

[54] Synthesis of new thiazolyl-pyrazolyl-1,2,3-triazole derivatives as potential antimicrobial agents.

[55] Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents.

[56] Design, synthesis, modeling studies and biological screening of novel pyrazole derivatives as potential analgesic and anti-inflammatory agents.

[57] Synthesis of coumarin derivatives and its Ru(II) complexes encompassing pyrazole ring as a potent antidiabetic agents – A biochemical perspective

[58] Design, Synthesis, and Evaluation of Some Novel Heterocycles Bearing Pyrazole Moiety as Potential Anticancer Agents

[59] Agents Modeling Experience Applied To Control Of Semi-Continuous Production Process

[60] Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.

[61] Diselenides and Benzisoselenazolones as Antiproliferative Agents and Glutathione-S-Transferase Inhibitors

[62] Silver Nanoparticles as Potential Antibacterial Agents

[63] Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-D-ribofuranose 2'-Oxidase.

[64] Synthesis, Biological Evaluation and In Silico Computational Studies of 7-Chloro-4-(1-1,2,3-triazol-1-yl)quinoline Derivatives: Search for New Controlling Agents against (Lepidoptera: Noctuidae) Larvae.

[65] Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains

[66] Synthesis and biological evaluation of bergenin-1,2,3-triazole hybrids as novel class of anti-mitotic agents

[67] Antineoplastic agents 540. The Indian Gynandropsis gynandra (Capparidaceae).

[68] efficacy of chlorhexidine and a riboflavin/UVA combination on fungal agents of keratitis.

[69] Potential for repurposing the personal care product preservatives bronopol and bronidox as broad-spectrum antibiofilm agents for topical application.

[70] Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

[71] Recent advances in the treatment of C. difficile using biotherapeutic agents

[72] Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

[73] Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents

[74] Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

[75] Antimicrobial activities of ceftazidime&ndash;avibactam, ceftolozane&ndash;tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

[76] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

[77] Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

[78] In vitro activity of ceftazidime&ndash;avibactam, ceftolozane&ndash;tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

[79] The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agents

[80] Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents [Corrigendum]

[81] Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

[82] Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-na&iuml;ve hepatitis C genotype 1b-infected patients in western China

[83] Peptidomimetics as a new generation of antimicrobial agents: current progress

[84] New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

[85] Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

[86] Emerging agents to combat complicated and resistant infections: focus on ceftobiprole

[87] Combining antihypertensive and antihyperlipidemic agents &ndash; optimizing cardiovascular risk factor management

[88] Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness

[89] Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation

[90] Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

[91] Recent advances in the treatment of C. difficile using biotherapeutic agents

[92] Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

[93] Recent advances in the treatment of C. difficile using biotherapeutic agents

[94] Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

[95] Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents

[96] Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

[97] Antimicrobial activities of ceftazidime&ndash;avibactam, ceftolozane&ndash;tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

[98] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

[99] Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

[100] In vitro activity of ceftazidime&ndash;avibactam, ceftolozane&ndash;tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

[101] The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agents